Skip to content

Retrospective Study on Botulinum Toxin Type A Injection for Spasticity after Stroke/Traumatic Brain Injury

Retrospective Study on Botulinum Toxin Type A Injection for Spasticity after Stroke/Traumatic Brain Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110468
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-10-14
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity

Interventions

Recovery Phase Group:NA
Chronic Phase Group:NA

Sponsors

Shanghai Yangzhi rehabilitation hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with stroke or traumatic brain injury (TBI) with clinically significant spasticity in at least one muscle group (modified Ashworth scale score MAS>=1+); 2. Age>=18 years old; 3. Completion of botulinum toxin A injection and follow-up evaluation at 1 month after treatment;

Exclusion criteria

Exclusion criteria: 1. Presence of neuromuscular diseases other than stroke/TBI (such as Parkinson's disease, multiple sclerosis); 2. History of surgical interventions for spasticity (e.g., tendon lengthening, selective dorsal rhizotomy); 3. Contraindications to botulinum toxin A injection (e.g., allergy, infection at the injection site).

Design outcomes

Primary

MeasureTime frame
Modified Ashworth Scale;

Secondary

MeasureTime frame
Modified Barthel Index;Berg Balance Scale;

Countries

China

Contacts

Public ContactLiwen Wang

Shanghai Yangzhi rehabilitation hospital

wlw916@126.com+86 21 3773 0022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026